Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sitagliptin (50mg) + Glimepiride (2mg) + Metformin (1000mg) SR Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹195/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sitagliptin 50mg + Glimepiride 2mg + Metformin 1000mg SR Tablet is a fixed-dose triple combination indicated for the treatment of type 2 diabetes mellitus in patients who require enhanced and sustained blood glucose control.
This formulation works through multiple complementary mechanisms—sitagliptin improves incretin activity and insulin release, glimepiride stimulates pancreatic insulin secretion, and metformin reduces hepatic glucose production while improving peripheral insulin sensitivity.
Clinically, it is prescribed for patients with poor glycemic control on dual therapy, helping regulate both fasting and postprandial blood glucose levels and lowering the risk of diabetes-related complications.
With increasing demand for high-strength, comprehensive diabetes therapies, this combination strengthens treatment portfolios, supports consistent prescriptions, and helps expand reach among physicians managing complex diabetic cases.
Common side effects may include nausea, diarrhea, abdominal discomfort, dizziness, or headache. Hypoglycemia may occur, especially when combined with other antidiabetic agents. Rarely, lactic acidosis or allergic reactions may occur.
Istalab GM 2/1000 Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood glucose levels are not adequately controlled with diet and exercise alone. It helps in achieving better fasting and postprandial blood glucose control as advised by a physician.
Use this medicine strictly under medical supervision. Follow the prescribed dosage and timing. Regular monitoring of blood glucose is essential. Caution is advised in patients with renal impairment, hepatic disorders, or elderly patients.
Store below 25°C in a cool, dry place. Protect from moisture. Keep out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sitagliptin 50mg + Glimepiride 2mg + Metformin 1000mg SR Tablet has strong demand in the diabetology, endocrinology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic portfolios.
Medical distributors and agencies can benefit from growing demand for Type 2 diabetes management under medical supervision. Sitagliptin 50mg is a DPP-4 inhibitor that helps improve glycemic control by enhancing the body's natural incretin activity Glimepiride 2mg is a sulfonylurea that helps stimulate insulin release from the pancreas Metformin 1000mg SR helps reduce hepatic glucose production and improve insulin sensitivity with sustained-release action for prolonged glucose control Commonly prescribed for Type 2 diabetes mellitus when multiple mechanisms of blood glucose control are required Provides comprehensive glycemic management through complementary therapeutic actions Widely prescribed by diabetologists, endocrinologists, and general physicians This strengthens a comprehensive diabetes and metabolic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sitagliptin 50mg + Glimepiride 2mg + Metformin 1000mg SR Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.